You just read:

New Data from Oncopeptides Phase 1/2 O-12-M1 Trial Evaluating Melflufen in RRMM Presented at 2019 ASCO Annual Meeting

News provided by

Oncopeptides AB

03 Jun, 2019, 14:22 BST